recombinant anti-IgE Fabs (Glycobia)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namerecombinant anti-IgE Fabs (Glycobia)
Drug Alias Nameanti-immunoglobulin E antibodies (Glycobia)recombinant anti-immunoglobulin E antigen binding fragments (Glycobia)
ClassificationBiologics > Protein drugs > Recombinant proteinBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionImmunoglobulin E inhibitors
TargetsImmunoglobulin E
Therapy Area/IndicationsImmune System DiseasesAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGlycobia Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlycobia Inc
Active IndicationsN/A
Inactive IndicationsImmune System DiseasesAsthma

Other Information

ATC CodeN/A
Related LinksN/A